← Back to Search

Cannabidiol (CBD) for Post-Traumatic Stress Disorder

Phase 1 & 2
Waitlist Available
Led By Casey Straud, PsyD
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, day 4, day 8, day 15 and at about 45 days (1 month follow-up visit)
Awards & highlights

Study Summary

This trial will test whether CBD can be safely used alongside exposure therapy to help people with PTSD.

Eligible Conditions
  • Post-Traumatic Stress Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 4, day 8, day 15 and at about 45 days (1 month follow-up visit)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 4, day 8, day 15 and at about 45 days (1 month follow-up visit) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinician Administered PTSD Scale (CAPS-5)
Posttraumatic Stress Disorder Checklist (PCL-5)
Secondary outcome measures
Brief Inventory of Psychosocial Functioning (BIPF)
Depressive Symptoms Index-Suicidality Subscale (DSI-SS)
Generalized Anxiety Disorder Screener (GAD-7)
+4 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Cannabidiol (CBD)Active Control2 Interventions
Epidiolex oral solution 500mg (5ml) per day
Group II: PlaceboPlacebo Group2 Interventions
Placebo oral solution 5ml per day

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

National Center for Advancing Translational Sciences (NCATS)NIH
320 Previous Clinical Trials
401,708 Total Patients Enrolled
The University of Texas Health Science Center at San AntonioLead Sponsor
452 Previous Clinical Trials
91,392 Total Patients Enrolled
Casey Straud, PsyDPrincipal InvestigatorUniversity of Texas Health Science Center San Antonio
1 Previous Clinical Trials
40 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are included in the enrollment for this trial?

"Affirmative. Clinicaltrials.gov's archives reveal that this clinical trial, initially posted on April 4th 2022 is still in search of candidates to participate. 1 facility needs to enlist 28 participants for the project."

Answered by AI

Can you summarize the outcomes of other investigations into Cannabidiol (CBD)?

"Currently, 79 studies examining the efficacy of Cannabidiol (CBD) are being conducted with 16 in their third phase. While many trials originate from Ribeirao Preto, Sao Paulo, there exists a total of 289 clinical trial centres worldwide involved in research on CBD."

Answered by AI

Are there any recruitment opportunities for this clinical research at the moment?

"Per the clinicaltrials.gov page, this medical trial is in need of participants. It was first launched on April 4th 2022 and last altered on May 3rd 2022."

Answered by AI

With what goal is this experiment striving to accomplish?

"This trial will be assessed across several time points, including Baseline, Day 4, Day 8, Day 15 and after approximately 45 days. The primary outcome measure is the Clinician Administered PTSD Scale (CAPS-5). Secondary outcomes include Patient Health Questionnaire-9 (PHQ-9), Brief Inventory of Psychosocial Functioning (BIPF) and Posttraumatic Cognitions Inventory (PTCI)."

Answered by AI

Is this research endeavor looking for participants of a certain age bracket or older?

"To be eligible for this research, an individual should have crossed the age of 18 yet remained under 65 years old."

Answered by AI

Could I qualify for enrollment in this research project?

"This research project is welcoming 28 participants aged 18-65 with moral injury. Eligibility requirements include being within the designated age range, having English language fluency, and a diagnosis of PTSD as verified by Clinician-Administered Posttraumatic Stress Scale (CAPS-5). Candidates must also have been on an unchanged medication regimen for at least one month before beginning this trial."

Answered by AI

Who else is applying?

What state do they live in?
Louisiana
Texas
How old are they?
18 - 65
What site did they apply to?
University of Texas Health Science Center at San Antonio - STRONG STAR Northwest Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
1
3+

Why did patients apply to this trial?

Everyone speaks highly of CBD. I never tried it.
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

How long? How much does it pay? How much is the payment for the trial?
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder
Casey Straud 2022. "Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05132699.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top